COST-EFFECTIVENESS OF BRIVARACETAM VERSUS OTHER ANTIEPILEPTIC DRUGS USED AS ADJUNCTIVE TREATMENT FOR FOCAL SEIZURES IN THE UK: A DISCRETE EVENT SIMULATION MODEL